| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 99.491 | 100.646 | 108.481 | 113.650 | 101.772 | 103.747 | 124.933 | 104.867 | 114.515 | 154.808 |
| Total Income - EUR | 101.560 | 100.796 | 108.505 | 113.652 | 101.775 | 103.750 | 124.944 | 104.874 | 114.516 | 159.215 |
| Total Expenses - EUR | 101.364 | 107.269 | 88.557 | 98.255 | 92.491 | 91.640 | 91.682 | 86.071 | 99.595 | 142.766 |
| Gross Profit/Loss - EUR | 196 | -6.473 | 19.948 | 15.397 | 9.284 | 12.111 | 33.263 | 18.802 | 14.921 | 16.449 |
| Net Profit/Loss - EUR | 196 | -7.480 | 18.863 | 14.261 | 8.267 | 11.349 | 32.027 | 17.911 | 13.833 | 12.341 |
| Employees | 10 | 11 | 9 | 9 | 9 | 8 | 8 | 6 | 6 | 6 |
Check the financial reports for the company - Policlinica 3S S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.035 | 3.850 | 3.627 | 2.291 | 1.266 | 2.928 | 15.044 | 34.838 | 20.856 | 29.181 |
| Current Assets | 34.294 | 28.659 | 36.025 | 53.199 | 18.772 | 22.744 | 25.371 | 16.837 | 13.171 | 22.317 |
| Inventories | 3 | 3 | 0 | 215 | 211 | 0 | 0 | 377 | 0 | 0 |
| Receivables | 10.452 | 5.351 | 9.426 | 12.792 | 8.737 | 8.180 | 6.917 | 3.362 | 2.665 | 2.593 |
| Cash | 23.839 | 23.305 | 26.599 | 40.192 | 9.824 | 14.564 | 18.454 | 13.098 | 10.506 | 19.724 |
| Shareholders Funds | 35.370 | 27.530 | 32.792 | 46.451 | 11.672 | 15.400 | 34.637 | 42.517 | 25.457 | 26.729 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.959 | 4.979 | 6.859 | 9.038 | 8.366 | 10.272 | 5.777 | 9.159 | 8.570 | 24.769 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Policlinica 3S S.r.l.